Clinical Trial Update: Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

An exploratory Phase 2 clinical trial evaluating MT-8554 for Painful Diabetic Peripheral Neuropathy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Peripheral Neuropathy

Drugs mentioned

• MT-8554

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Painful Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED